Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome-Reference-Cited by-同舟云学术

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

Published:2010-04 Issue:4 Volume:16 Page:482-489
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kasamon Yvette L.,Luznik Leo,Leffell Mary S.,Kowalski Jeanne,Tsai Hua-Ling,Bolaños-Meade Javier,Morris Lawrence E.,Crilley Pamela A.,O'Donnell Paul V.,Rossiter Nancy,Huff Carol Ann,Brodsky Robert A.,Matsui William H.,Swinnen Lode J.,Borrello Ivan,Powell Jonathan D.,Ambinder Richard F.,Jones Richard J.,Fuchs Ephraim J.

Funder

National Institutes of Health

Leukemia and Lymphoma Society of America

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings;Szydlo;J Clin Oncol,1997

2. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma;Anasetti;Hum Immunol,1990

3. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion;Ash;Bone Marrow Transplant,1991

4. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implications for its molecular mechanism;Kawase;Blood,2007

5. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000);Kanda;Blood,2003

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients;Toxicology and Applied Pharmacology;2024-10

2. Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide;Bone Marrow Transplantation;2024-08-24

3. Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation;Frontiers in Immunology;2024-08-19

4. Post-Transplant-Cyclophosphamide and short-term Everolimus as Graft-versus-Host-Prophylaxis in a real –world cohort of patients with refractory T- and B-cell Lymphoma;2024-08-17

5. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-08